Capricor Therapeutics (CAPR) Change in Acquisitions & Divestments (2013 - 2026)

Capricor Therapeutics' Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $31.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 28.27% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $248.4 million (up 120.52% YoY), while the FY2025 annual figure was $260.6 million, up 177.83% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $31.0 million, down from $63.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $78.2 million in Q3 2025, with the low at $14.0 million in Q2 2022.
• The 5-year median for Change in Acquisitions & Divestments is $30.5 million (2022), against an average of $35.8 million.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments slumped 48.86% in 2023, then surged 278.14% in 2025.
• Capricor Therapeutics' Change in Acquisitions & Divestments stood at $38.4 million in 2022, then tumbled by 48.86% to $19.6 million in 2023, then dropped by 14.89% to $16.7 million in 2024, then soared by 278.14% to $63.2 million in 2025, then plunged by 50.96% to $31.0 million in 2026.
• Business Quant data shows CAPR's Change in Acquisitions & Divestments at $31.0 million in Q1 2026, $63.2 million in Q4 2025, and $78.2 million in Q3 2025.